Increased Gi protein signaling potentiates the negative chronotropic effect of adenosine in the SHR right atrium

Naunyn-Schmiedeberg's Archives of Pharmacology
Juliano Quintella Dantas RodriguesRosely O Godinho

Abstract

Hypertension is a risk factor for cardiovascular diseases, which have been associated with dysfunction of sympathetic and purinergic neurotransmission. Therefore, herein, we evaluated whether modifications of adenosine receptor signaling may contribute to the cardiac dysfunction observed in hypertension. Isolated right atria from spontaneously hypertensive (SHR) or normotensive Wistar rats (NWR) were used to investigate the influence of adenosine receptor signaling cascade in the cardiac chronotropism. Our results showed that adenosine, the endogenous agonist of adenosine receptors, and CPA, a selective agonist of A1 receptor, decreased the atrial chronotropism of NWR and SHR in a concentration- and time-dependent manner, culminating in cardiac arrest (0 bpm). Interestingly, a 3-fold lower concentration of adenosine was required to induce the negative chronotropic effect in SHR atria. Pre-incubation of tissues from both strains with DPCPX, a selective A1 receptor antagonist, inhibited the negative chronotropic effect of CPA, while simultaneous inhibition of A2 and A3 receptors, with ZM241385 and MRS1523, did not change the adenosine chronotropic effects. Moreover, 1 μg/ml pertussis toxin, which inactivates the Gαi protein subun...Continue Reading

References

Apr 1, 1992·Pharmacological Research : the Official Journal of the Italian Pharmacological Society·I Azevedo, W Osswald
May 1, 1991·Pharmacological Research : the Official Journal of the Italian Pharmacological Society·G FassinaL Caparrotta
Jan 25, 1991·European Journal of Pharmacology·A MatiasI Azevedo
Dec 1, 1990·Metabolism: Clinical and Experimental·A GreenD J DiPette
Jan 1, 1990·Annals of the New York Academy of Sciences·A PellegE L Michelson
Apr 1, 1989·Canadian Journal of Physiology and Pharmacology·A N Wilson, K J Broadley
Apr 1, 1982·Physiological Reviews·B Folkow
Oct 1, 1995·Pflügers Archiv : European journal of physiology·J A Brock, D F Van Helden
Apr 12, 1996·Molecular and Cellular Biochemistry·M B Anand-Srivastava
Feb 5, 1999·Naunyn-Schmiedeberg's Archives of Pharmacology·E OnginiB B Fredholm
Dec 11, 1999·European Journal of Pharmacology·N M Gardner, K J Broadley
Mar 29, 2001·Physiological Reviews·G Vassort
Mar 1, 1959·British Journal of Pharmacology and Chemotherapy·O ARUNLAKSHANA, H O SCHILD
Nov 5, 2003·Journal of Hypertension·Judith A Whitworth, UNKNOWN World Health Organization, International Society of Hypertension Writing Group
Dec 6, 2003·Pharmacological Reviews·Richard R NeubigUNKNOWN International Union of Pharmacology Committee on Receptor Nomenclature and Drug Classification
Jul 1, 2004·Pharmacological Research : the Official Journal of the Italian Pharmacological Society·Kai Tuovinen, Juhani Tarhanen
Jun 1, 2005·Vascular Pharmacology·John P Headrick, Jason Peart
Mar 7, 2006·Nature Reviews. Drug Discovery·Kenneth A Jacobson, Zhan-Guo Gao
Jan 12, 1927·The Journal of Physiology·E H Starling, M B Visscher
Sep 1, 1949·British Journal of Pharmacology and Chemotherapy·H O SCHILD
Mar 28, 2008·Purinergic Signalling·David Erlinge, Geoffrey Burnstock
May 20, 2008·Cellular and Molecular Life Sciences : CMLS·A V Smrcka
Oct 15, 2008·Brazilian Journal of Medical and Biological Research = Revista Brasileira De Pesquisas Médicas E Biológicas·G Burnstock
May 16, 2009·Current Hypertension Reports·Paolo Palatini, Stevo Julius
Sep 1, 1947·British Journal of Pharmacology and Chemotherapy·H O SCHILD
Apr 8, 2010·Current Topics in Medicinal Chemistry·M L TrincavelliC Martini
Oct 12, 2010·Journal of Molecular and Cellular Cardiology·Neil HerringDavid J Paterson
Oct 30, 2010·The Journal of Pharmacology and Experimental Therapeutics·Terry Kenakin
Nov 5, 2011·Current Hypertension Reports·Sándor Bátkai, Thomas Thum
Nov 18, 2011·FASEB Journal : Official Publication of the Federation of American Societies for Experimental Biology·Yassine SassiJean-Sébastien Hulot
Jun 1, 2009·Current Protocols in Pharmacology·S Jamal MustafaWorku Abebe
Mar 23, 2012·The Journal of Pharmacology and Experimental Therapeutics·Thiago DuarteRosely Oliveira Godinho
Jun 15, 2013·Pharmacology & Therapeutics·John P HeadrickJason N Peart
Jul 28, 2013·The Journal of Pharmacology and Experimental Therapeutics·Magdolna LevayThomas Wieland

❮ Previous
Next ❯

Citations

Sep 14, 2019·Journal of Cardiovascular Pharmacology·Juliano Quintella Dantas RodriguesAron Jurkiewicz

❮ Previous
Next ❯

Software Mentioned

GraphPad Prism
GraphPad

Related Concepts

Related Feeds

Cardiovascular Disease Pathophysiology

Cardiovascular disease involves several different processes that contribute to the pathological mechanism, including hyperglycemia, inflammation, atherosclerosis, hypertension and more. Vasculature stability plays a critical role in the development of the disease. Discover the latest research on cardiovascular disease pathophysiology here.